Brahmajee K. Nallamothu, MD, MPH

Some of the renal tubular cell effects of amphotericin B are due to the ability of this polyene to bind to cholesterol in the plasma membrane and form aqueous pores gastritis alcohol order 100 mcg misoprostol free shipping. In the presence of amphotericin B gastritis diet 7-up misoprostol 200 mcg buy mastercard, cells of the turtle and rat distal tubule do not produce a normal net outward flux of protons gastritis diet symptoms order misoprostol discount, due to an increase in proton permeability (Steinmetz and Husted gastritis mind map order 200 mcg misoprostol with amex, 1982; Gil and Malnic gastritis symptoms diarrhea generic 100 mcg misoprostol visa, 1989). The hypokalemia observed with amphotericin B may be due to an increase in luminal potassium ion permeability in the late distal tubule and the cortical collecting duct and the loss of potassium ions in the urine. Cyclosporine Cyclosporine is an important immunosuppressive agent and is widely used to prevent graft rejection in organ transplantation (Charney et al. Cyclosporine is a fungal cyclic polypeptide and acts by selectively inhibiting cyclophylin and, in turn, calcineurin and T-cell activation. Nephrotoxicity is a critical side effect of cyclosporine, with nearly all patients who receive the drug exhibiting some form of nephrotoxicity. Endothelin may contribute to constriction of the afferent arteriole because endothelin receptor antagonists inhibit cyclosporine-induced vasoconstriction (Lanese and Conger, 1993). Although cyclosporine can produce proximal tubular epithelial changes (many small equally sized vacuoles in the cytosol), it is still not clear whether a direct effect of cyclosporine on tubular cells plays a significant role in the nephrotoxicity. Acute vasculopathy or thrombotic microangiopathy is a rather unusual nephrotoxic lesion that affects arterioles and glomerular capillaries, without an inflammatory component, following cyclosporine treatment. The lesion consists of fibrin-platelet thrombi and fragmented red blood cells occluding the vessels (Charney et al. Although the characteristics of this lesion differ from the vascular changes of acute rejection, a variety of factors may contribute to this lesion in the clinical transplant setting. Long-term treatment with cyclosporine can result in chronic nephropathy with interstitial fibrosis and tubular atrophy. Histologic changes are profound; they are characterized by arteriolopathy, global and segmental glomerular sclerosis, striped interstitial fibrosis, and tubular atrophy. These lesions may not be reversible if cyclosporine therapy is discontinued and may result in end-stage renal disease. Although the mechanism of chronic cyclosporine nephropathy is not known, vasoconstriction probably plays a contributing role. The marked interstitial cell proliferation and increased procollagen secretion that occurs following cyclosporine administration may contribute to the interstitial fibrosis (Racusen and Solez, 1993). At this time, the degree and incidence of nephrotoxicity and morphologic changes associated with tacrolimus exposure are similar to that exhibited with cyclosporine, suggesting similar modes of toxic action. The mechanism by which cisplatin produces cellular injury is not known but may involve metabolites of cisplatin. For example, in a mouse model of cisplatin-induced nephrotoxicity the inhibition of -glutamyl transpeptidase or cysteine S-conjugate -lyase blocked toxicity, suggesting that cisplatin­glutathione conjugates may be important in targeting cisplatin to the kidney and its resulting nephrotoxicity (Townsend and Hanigan, 2002). Uptake of cisplatin in to tubular cells is thought to be mediated by organic cation transporter 2. Interestingly, the trans isomer of cisplatin is not nephrotoxic even though similar concentrations of platinum are observed in the kidney after dosing. Thus, it is not the platinum atom per se that is responsible for the toxicity but rather the geometry of the complex or a metabolite. The antineoplastic and perhaps the nephrotoxic effects of cisplatin may be due to its intracellular hydrolysis to the reactive mono-chloro-mono-aquodiammineplatinum or diaquo-diammine-platinum species and the ability of these metabolites to alkylate purine and pyrimidine bases. In vitro studies using primary cultures of mouse proximal tubular cells revealed that the type of cell death produced by cisplatin is dependent on the concentration (Lieberthal et al. At cisplatin concentrations less than 100 µM, the primary form of cell death is apoptosis. As the concentration increases above 100 µM, a greater percentage of the cells die by oncosis. In addition, cisplatin is known to induce mitochondrial dysfunction and activates numerous pathways in the mitogen-activated protein kinase family (Francesca to et al. Finally, primarily through the use of antioxidants, in vivo and in vitro studies support a role for oxidative stress in cisplatin-induced nephrotoxicity (Bonegio and Lieberthal, 2005). The lack of complete return of renal function following cisplatin treatment in vivo may result from the interference of cisplatin with the normal proliferative response that occurs after injury. The kidney is not only responsible for the majority of cisplatin excreted but is also the primary site of accumulation. The effects of cisplatin on the kidney are several, including acute and chronic renal failure, renal magnesium wasting, and polyuria and patients treated with cisplatin regimens permanently lose 10% to 30% of their renal function (Bonegio and Lieberthal, 2005; Sanchez-Gonzalez et al. The nephrotoxicity of cisplatin can be grouped as (1) tubular toxicity, (2) vascular damage, (3) glomerular injury, and (4) interstitial injury. Radiocontrast Agents Iodinated contrast media are used for the imaging of tissues, with two major classes of compounds currently in use. The ionic compounds, diatrizoate derivatives, are (1) ionized at physiologic pH, (2) not significantly bound to protein, (3) restricted to the extracellular space, (4) almost entirely eliminated by the kidney, and (5) freely filtered by the glomerulus and neither secreted nor reabsorbed. These agents have a very high osmolality (>1200 mOsm/L) and are potentially nephrotoxic, particularly in patients with existing renal impairment, diabetes, or heart failure or who are receiving other nephrotoxic drugs. The newer contrast agents (eg, iotrol, iopamidol) are nonionic owing to the addition of an organic side chain, their low osmolality, and their lower nephrotoxicity. The nephrotoxicity of these agents is due to both hemodynamic alterations (vasoconstriction) and proximal tubular injury (Koyner et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Determinants of glomerular permselectivity: insights derived from observations in vivo. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of glomerular sclerosis in angina, renal ablation and intrinsic renal disease. Transport activity modifies thick ascending limb damage in isolated perfused kidney. Nephrotoxicity of cyclosporine and other immunosuppressive and immunotherapeutic agents. Regulation of the cellular stress response by reactive electrophiles: the role of covalent binding and cellular thiols in transcriptional activation of the 70-kDa heat shock protein gene by nephrotoxic cysteine conjugates. Correlation of functional and morphologic changes and their modification by clonidine. Evidence of a role for in situ activation in selective covalent binding and toxicity. In vitro techniques in screening and mechanistic studies: cell culture, cell-free systems, and molecular and cell biology. Effect of zinc pretreatment on mercuric chloride-induced lipid peroxidation in the rat kidney. Relationship between stress protein induction in rat kidney by mercuric chloride and nephrotoxicity. Mercury induces regional and cell-specific stress protein expression in rat kidney. Differential cellular effects in the toxicity of haloalkene and haloalkane cysteine conjugates to rabbit renal proximal tubules. The role of lipid peroxidation in renal proximal tubule cell death induced by haloalkene cysteine conjugates. Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptor. Cysteine conjugate toxicity, metabolism and binding to macro-molecules in isolated rat kidney mitochondria. Formation of mitochondrial phospholipid adducts by nephrotoxic cysteine conjugate metabolites. Formation of diflourothionoacetylprotein adducts by S-(1,1,2,2-tetrafluoroethyl)-l-cysteine metabolites: nucleophilic catalysis of stable lysyl adduct formation by histidine and tyrosine. Current status of the structural and functional basis of glomerular filtration and proteinuria. Identification of gene family cf caspases in rat kidney and altered expression in ischemia-reperfusion injury. In vitro techniques in screening and mechanistic studies: organ perfusion, slices, and nephron components. Altered localization of 73-kilodalton heat shock protein in rat kidneys with gentamicin­induced acute tubular injury. The pathogenesis and prevention of radiocontrast medium-induced renal dysfunction. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. The nomenclature of cell death: recommendations of an ad hoc committee of the society of toxicologic pathologists. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. Calpain mediates progressive plasma membrane permeability and proteolysis of cytoskeleton-associated paxillin, talin, and vinculin during renal cell death. Protein kinase C-alpha inhibits the repair of oxidative phosphorylation after S-(1,2-dichlorovinyl)-L-cysteine injury in renal cells. An alternative hypothesis on the role of chemically induced protein droplet (2u-globulin) nephropathy in renal carcinogenesis. Cytoprotection by inhibition of chloride channels: the mechanism of action of glycine and strychnine. Inhibitors of renal chloride transport do not block toxicant-induced chloride influx in the proximal tubule. Protein kinase C mediates repair of mitochondrial and transport functions after toxicant-induced injury in renal cells. Protein kinase C- epsilon modulates mitochondrial function and active Na+ transport after oxidant injury in renal cells. Protein kinase C- varepsilon activation induces mitochondrial dysfunction and fragmentation in renal proximal tubules. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Mitogen-activated protein kinases contribute to reactive oxygen species-induced cell death in renal proximal tubule epithelial cells. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Pentachlorabutadienyl-l-cysteine uncouples oxidative phosphorylation by dissipating the proton gradient. A mechanism of S -(1,2,3,4,4pentachloro-1,3-butadienyl)-l-cysteine toxicity to rabbit renal proximal tubules. Akt activation improves oxidative phosphorylation in renal proximal tubular cells following nephrotoxicant injury. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Inhibition of tglutamyl transpeptidase or cysteine S-conjugate -lyase activity blocks the nephrotoxicity of cisplain in mice. Toxicity of S-pentachorobutadienyll-cysteine studied with isolated rat renal cortical mitochondria. Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Calpains mediate calcium and chloride influx during the late phase of cell injury. Depletion of endoplasmic reticulum calcium stores protects against hypoxia- and mitochondrial inhibitor-induced cellular injury and death. Functional alterations of renal cortical mitochondria isolated after mercuric chloride treatment. Mitochondrial bioenergetics during the initiation of mercuric chloride-induced renal injury: I. Direct effects of in vitro mercuric chloride on renal cortical mitochondrial function. Tumor necrosis factor mediates apoptosis via Ca2+/Mg2+ dependent endonuclease with protein kinase C as a possible mechanism for cytokine resistance in human renal carcinoma cells. Requirement of the epidermal growth factor receptor in renal epithelial cell proliferation and migration. Extracellular signal-regulated kinase activation mediates mitochondrial dysfunction and necrosis induced by hydrogen peroxide in renal proximal tubular cells. Pathological changes in the respiratory tract also can be a target of blood-borne agents. Inhalation toxicology refers to the route of exposure, whereas respiratory toxicology refers to target organ toxicity. This chapter reviews the toxic responses of the respiratory system and is an update of the previous chapter (Witschi et al. Historically, respiratory toxicology is a keystone of medicine, dating back to Hippocrates. In his medical thesis On Airs, Waters, and Places, Hippocrates recommended that physicians evaluate local atmospheres to discover the causes of diseases (Adams, 1849). In 1661, John Evelyn appealed to the English King and Parliament for relief from the poor air quality of London that was a result of the burning of "sea-coale" (a brown coal likely enriched in sulfur that washed up on the banks of the River Thames (Evelyn, 1661). This situation continued and became worse in the 19th century when the Industrial Revolution quickened awareness of respiratory toxicology due to air pollutions (see Chap. Later, Bernardino Ramazzini proposed that clinicians evaluate the relationships between occupational atmospheres and disease pathogenesis, starting a long history of respiratory toxicology role in occupational medicine.

The role of pulmonary alveolar macrophages in the ingestion of silica is an initiating event gastritis diet òåëåïðîãðàììà buy discount misoprostol online. Macrophages phagocytose silica particles in to phagosomes that fuse with endosomes during the internalization process (Costantini et al atrophic gastritis symptoms uk 200 mcg misoprostol buy with mastercard. Similar to the fate of microorganisms gastritis diet çùêòù generic misoprostol 200 mcg visa, macrophages experience phagosomal destabilization (Hornung et al gastritis symptoms tiredness misoprostol 200 mcg purchase. In contrast to microorganisms chronic gastritis management order misoprostol cheap online, silica particles cannot be degraded and macrophages undergo cell death, releasing these particles that are engulfed by other macrophages, thus perpetuating the process of phagocytosis and cell death (Huaux, 2007). Below are two more examples that have had toxicological significance in clinical settings. In many tissues, the cytosolic enzyme bleomycin hydrolase inactivates bleomycin (Schwartz et al. In lung and skin, two target organs for bleomycin toxicity, the activity of this enzyme is low compared with that in other organs. Animal models of belomycin-induced pulmonary fibrosis have been used to study the efficacy of promising antifibrotic drugs (Giri, 2003) and stem cell therapy (Ortiz et al. The undesirable side effects include hemorrhagic cystitis and pulmonary fibrosis (Fraiser et al. Cyclophosphamide is metabolized by the cytochrome P450 system to two highly reactive metabolites: acrolein and phosphoramide mustard. Although the exact mechanism of action for causing lung damage has not been established, studies with isolated lung microsomes have shown that cyclophosphamide and its metabolite acrolein initiate lipid peroxidation (Patel and Block, 1985). In humans, a doserelated pulmonary toxicity is often noticed first by a decrease in diffusion capacity, which can develop in to fatal pulmonary fibrosis (Weiss et al. Naphthalene Naphthalene occurs in cigarette smoke, tars, petroleum and is a precursor in the chemical synthesis of tanning agents, phthalic acid anhydride, carbaryl, and 2-naphthol. In laboratory animals, inhaled or parenterally administered naphthalene produces extensive necrosis in the bronchiolar epithelium of the mouse but much less necrosis in the airways of rats, hamsters, or monkeys (Buckpitt et al. The primary target in the surface epithelium is the bronchiolar secretoglobin cells. These cells were thought to be very important because they contain a stem cell subpopulation. They were once thought to be capable of cellular maintenance of the epithelium in bronchi, bronchioles, and alveolar regions. However, recent evidence suggests that these cells are only involved in the long-term maintenance and repair of airways but not alveolar epithelium (Rawlins et al. In rats and other species, including monkeys, conversion of naphthalene is less stereospecific and the rates of formation of the epoxide are much slower than in mice (Buckpitt et al. Naphthalene epoxides may subsequently be conjugated with glutathione and form adducts that are eliminated as mercapturic acids. The epoxide can undergo rearrangement to 1-naphthol with subsequent metabolism to quinones, which are potentially toxic compounds. Naphthalene metabolites bind covalently to cellular proteins that are important in normal cellular homeostasis and protein folding and this may be related to the mechanism of toxicity by this chemical. Interestingly, in both mice and rhesus monkeys the total amount of adducted protein is similar (Lin et al. Blood-Borne Agents That Cause Pulmonary Toxicity in Humans A number of compounds administered systematically can enter the lung through pulmonary circulation and cause lung injury and disease. Additional tests evaluate the maximal flow rates and different lung volumes, diffusion capacity, oxygen, and carbon dioxide content of the arterial and venous blood, distribution of ventilation, and lung and chest wall compliance. The subject is asked first to inhale deeply and then to exhale the air as quickly as possible. The test is repeated typically three times and the result of the best effort is recorded. The test is often used in epidemiological studies or controlled clinical studies designed to assess the potential adverse effects of air pollutants. The structural properties that control gas exchange include the lung gas volume, the path length for diffusion in the gas phase; the thickness and area of the alveolar capillary membrane, and the volume of blood in capillaries supplying ventilated alveoli. The functional properties that control gas exchange include the uniformity of ventilation and perfusion with respect to each other, the diffusion characteristics of the alveolar membrane; the binding properties of hemoglobin (Hb) in the alveolar capillaries, and the gas tensions in blood in the pulmonary vascular bed that exchanges gas with the alveoli. Gas exchange may be hindered by the accumulation of fluids or cellular elements in the alveoli (edema, pneumonic infiltrates), thickening of the alveolar wall (fibrosis), insufficient ventilation of the alveolar region (emphysema), ventilation­perfusion mismatching, or insufficient presence of oxygen transport elements (reduced alveolar blood volume or reduced amount of Hb in the blood). The test is easy to perform in humans and laboratory animals and is widely used in clinical studies. Proper lung function in humans can be evaluated with several additional techniques. Computed tomography provides detailed roentgenographic information of airways and lung parenchyma and has been useful in screening high-risk patients for lung cancer (National Lung Screening Trial, 2011). As an experimental method, exhaled breath or induced sputum analysis may also be useful in assessing other inflammatory indicators in exhaled breath condensate such as oxidative stress markers (eg, hydrogen peroxide and isoprostanes), nitric oxide derivatives (eg, nitrate and nitrates), arachidonic acid metabolites (eg, prostanoids, leukotrienes, and epoxides), adenosine, and cytokines (Popov, 2011). Fiberoptic bronchoscopy has become one of the most valuable tools for the detection of toxic lung injury (Reynolds, 2011). The procedure allows direct visual inspection of the major lobar and segmental airways; the depth of penetration is limited by the external diameter of the bronchoscope, usually 5 mm. Bronchoscopy also allows the introduction and retrieval of saline solutions in to the lung and subsequent analysis for cellular and molecular constituents (broncholveolar lavage). Excision of small tissue samples (biopsies) during bronchoscopy is an additional diagnostic tool, most helpful in the evaluation and staging of precancerous and cancerous lesions. In such studies, selection of animals with a respiratory system similar to that of humans is particularly desirable (Phalen et al. However, the availability and cost of these animals and the necessity for special facilities for housing monkeys and performing long-term exposures, along with ethical considerations, including the confinement of primates in small exposure chambers for prolonged periods, severely limits the use of primates. Rats and mice are widely used, although fundamental differences in respiratory anatomy (eg, lack of respiratory bronchioles) and function (rats and mice are obligate nose breathers) can complicate the extrapolation of effects to humans. The following techniques are used to study the effects of inhaled toxicants in animals. Inhalation Exposure Systems In inhalation studies, animals are kept within a chamber that is ventilated with a defined test atmosphere (Phalen, 1976; Wong, 2007). Alternatively, wet chemical analysis procedures are applied after sampled gases from the chambers are bubbled through traps. More challenging is the generation of particles or complex mixtures (eg, tobacco smoke, diesel, and gasoline exhaust or residual oil fly ash), particularly because of the possibility of interactions between individual mixture constituents and the possibility of formation of artifacts (Pauluhn, 2005). Exposure chambers must allow for the rapid attainment of the desired concentrations of toxicants, maintenance of desired toxicant levels homogeneously throughout the chamber, adequate capacity for experimental animals, and minimal accumulation of undesired products associated with animal occupancy (usually ammonia, dander, heat, and carbon dioxide). As a general rule, the total body volume of the animals should not exceed 5% of the chamber volume. However, nose-only exposure systems create different problems, including a great deal of stress on the animals due to confinement during exposure, and the very labor-intensive handling that is required for exposures by this route. The proper selection of exposure techniques for a given chemical is ultimately a decision that must be made on a case-by-case basis. Finally, concern for the environment and the safety of facility personnel suggest prudence in how chambers are exhausted. Pulmonary Function Tests in Experimental Animals Conducting pulmonary function tests in experimental animals poses distinct challenges, especially in small rodents (Reinhard et al. Expiration is forced by applying external pressure to the thorax or negative pressure to the airways (Vinegar et al. Alternatively, analysis of pressure­ volume curves is a comparatively easy test to perform in animals, not requiring a specialized apparatus (Alarie et al. Compliance (volume/pressure) is calculated as the slope of the volume­pressure curve. The volume­pressure curve involves deflating the lung and then inflating the lung with incremental volumes and recording the pressure, and can be obtained from lungs filled with air and/or physiological saline. Compliance provides an indication of the intrinsic elastic properties of the lung parenchyma and, when measured in vivo, the thoracic cage. In emphysema, compliance of the lung increases because elatic recoil is decreased. When the inflation and deflation are performed with air, the curves will not match and this hysteresis is an indication of surfactant function. The use of saline is sensitive to structural changes in lung parenchyma, as the effects of surfactant are eliminated in a saline-filled lung. Another pulmonary function test is the analysis of airway resistance, which can be measured in laboratory animals by restrained plethysmography (Amdur and Mead, 1958), unrestrained video-assisted plethysmography (Bates et al. An increase in airway resistance is a measure of bronchoconstriction inasmuch as the airway smooth muscle contraction or airway mucosal edema narrows the airway lumen and obstructs airflow. Airway resistance also can be measured after a challenge of incremental doses of inhaled methacholine (or histamine) (Bates and Irvin, 2003) or infused acetylcholine (Swiecichowski et al. This challenge provides a measure of airway hyperreactivity, a distinguishing feature of asthma in humans. In asthma, resting airway resistance is typically normal but when challenged, airway resistance will increase at a lower threshold dose of methacholine. Analysis of breathing pattern can also be used and may differentiate between upper airway and lower airway irritants (Alarie et al. In rodents, upper airway ("sensory") irritants produce a breathing pattern of decreased respiratory frequency with increased tidal volume, whereas lower airway ("pulmonary") irritants produce a breathing pattern of increased respiratory frequency and decreased minute volume (ie, the total volume of air breathed in 1 minute). Morphological Techniques the pathology of acute and chronic injury may be examined by gross inspection and under the microscope and should include the nasal passages, larynx, major bronchi, and the lung parenchyma. Regional distribution of lesions in nasal passages can be assessed after fixation and decalcification. Various regions of the nasal passages can then be examined by obtaining cross sections at multiple levels. Proper fixation of the lung is done by vascular perfusion with fixative through the pulmonary artery or by instillation of fixative through the trachea. Perfusion fixation does not dislodge material (lining fluid, deposited particles) or cells in the lumen of the airways or the alveoli from their original position. Fixation by intratracheal instillation can be done under controlled pressure (usually 30 cm H2O in rodents), which preserves alveolar architecture. Formalin-based fixatives are satisfactory for routine histopathology, whereas the use of more sophisticated techniques such as electron microscopy, immunohistochemistry, and in situ hybridization require careful selection of the fixative. Paraffin sections of respiratory tract tissue are suitable for routine histopathological analysis of gross pathological changes, for example, inflammation, fibrosis, or lung tumors. Scanning electron microscopy allows visualization of the surface of interior lung structures, reveals alterations in the tissue surface, and detects rearrangement of the overall cell population. Confocal microscopy, consisting of a laser microscope coupled to a computer, allows examination of thick sections and discovery of specific cell types deep within the tissue labeled with fluorescent markers; it is an ideal tool for three-dimensional reconstruction of normal and damaged lung. Morphometry, the quantitative description of structure, refers to a quantitative analysis of tissue (Gehr et al. Measurements made in two dimensions on photographs taken under the microscope allow one to measure areas, the thickness of a structure, and numerical density. Using the appropriate formula, values such as the volume occupied by a specific cell population in the entire lung parenchyma can be calculated (Hyde et al. Additional tools for the study of toxic lung injury include immunohistochemistry, in situ hybridization, and analysis of cell kinetics. It is possible to identify cell types that carry certain enzymes and their anatomic locations. In situ hybridization allows one to visualize anatomic sites where a specific gene product is expressed, for example, collagen production in a fibrotic lung. Two useful sites to obtain lung-specific expression include the Human Protein Atlas (Uhlen et al. Ascribing a given metabolic capability to a specific cell type requires evaluation of gene expression and/or protein production in specific cells in situ. The normal adult lung is an organ for which under normal circumstances very few cells appear to die and to be replaced. When damaged by a toxic insult, the lung parenchyma is capable of repairing itself in an efficient manner. Flow cytometry is valuable in the study of cell populations prepared from the lung. The fluid lining the pulmonary epithelium can be recovered by bronchoalveolar lavage. Analysis of the lavage fluid is a useful tool to detect respiratory tract toxicity (Henderson, 2005; Reynolds, 2011). Influx of neutrophils or other leukocytes such as lymphocytes or eosinophils in to the lavage fluid is the most sensitive sign of inflammation. Lactate dehydrogenase activity (and its substituent isoenzymes), N-acetylglucosaminidase, acid or alkaline phosphatase, other lysosomal hydrolases, and sialic acid add additional information. In addition pulmonary edema can be assessed by determining lung wet:dry ratio or injection of Evan blue dye albumin (Patterson et al. In Vitro Studies Isolated Perfused Lung In vitro systems with materials originally obtained from either human tissues or experimental animals are particularly suited for the study of mechanisms that cause lung injury (Aufderheide, 2005; Bakand and Hayes, 2010). The methods include isolated perfused lung, microdissection/organotypic tissue culture systems, and cell type­specific cell culture. The isolated perfused lung method is applicable to lungs from many laboratory species (eg, mouse, rat, guinea pig, or rabbit) (Mehendale et al. The lung is perfused with blood or a blood substitute through the pulmonary arterial bed. At the same time, the lung is actively (through rhythmic inflation­deflation cycles with positive pressure) or passively (by creating negative pressure with an artificial thorax in which the lung is suspended) ventilated. Toxic agents can be introduced in to the perfusate or the inspired air (Rhoades, 1984). Repeated sampling of the perfusate allows one to determine the rate of metabolism of drugs and the metabolic activity of the lung.

Hyperplasia of the intraepithelial goblet cells occurs at the expense of ciliated cells in the lining epithelium gastritis pain treatment order 200 mcg misoprostol with mastercard. If the exacerbation is severe gastritis diet öåíà 200 mcg misoprostol order free shipping, the patient may deteriorate rapidly and require hospitalization gastritis diet book discount misoprostol. Grade 1 2 3 Degree of breathlessness related to activities Not troubled by breathlessness except on strenuous exercise Short of breath when hurrying or walking up a slight hill Walks slower than contemporaries on level ground because of breathlessness xanthomatous gastritis discount 100 mcg misoprostol with mastercard, or has to stop for breath when walking at own pace Stops for breath after walking about 100 metres or after a few minutes on level ground Too breathless to leave the house eosinophilic gastritis definition cheapest misoprostol, or breathless when dressing or undressing 4 5. This state is known as respiratory failure and is discussed in more detail elsewhere. In order to receive the benefits of long-term oxygen therapy, patients should breathe supplemental oxygen for at least 15 hours per day. In patients who become hypercapnic or acidotic on long-term oxygen therapy, regular non-invasive ventilation must be considered ­ this requires referral to a specialist centre. Pulmonary rehabilitation normally occurs in an outpatient setting with a multidisciplinary team. If introducing a long-acting anticholinergic (tiotropium), then short-acting cholinergic inhalers (ipratropium) need to be stopped. Inhaled corticosteroids are only used in combination with a long-acting b2 agonist and never alone. They have been shown to reduce the frequency of exacerbations as well as the risk of pneumonia. Commonly reported symptoms are worsening breathlessness, cough, increased sputum production and change in sputum colour. The severity of an exacerbation is assessed using the following tests: · Blood: evidence of a raised white cell count and C-reactive protein indicates the presence of infection. Management includes: · Controlled oxygen to maintain oxygen saturations between 88 and 92%; this is normally achieved with a Venturi mask. If patients have received multiple courses of steroids they will require a reducing-dose regimen to avoid rebound exacerbations when the steroids are stopped. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Aetiology is variable but they all present in a similar fashion, typically with shortness of breath and chestX-ray shadows. Though separately each disease is rare, collectively they affect 1/2000 of the population. The end stage is characterized by a honeycomb lung, a non-specific condition in which cystic spaces develop in fibrotic lungs with compensatory dilatation of unaffected neighbouring bronchioles. Clinical features Patients become progressively breathless and develop a dry, non-productive cough. On examination, lung expansion is reduced and fine end-inspiratory crackles are heard. Investigations Chest X-ray may show fine reticular, nodular or reticulonodular infiltration in the basal areas. Biopsy may be used to aid diagnosis; however, this can be difficult in older patients, who may not be suitable for surgery. Furthermore, there can be considerable differences in the interpretation of histological specimens. Lung function tests demonstrate a restrictive pattern along with a decreased transfer factor and can help monitor the progression of the disease. Pathogenesis the pathogenesis of pulmonary fibrosis is complex, involving many factors. The main features are: · A lesion affecting the alveolar-capillary basement membrane. Soluble immune complexes Sensitized alveolar T lymphocyte Complement components C3a, C5a Lymphokines Activated macrophage Interleukin-8 Treatment Treatment for pulmonary fibrosis is variable, depending on the underlying cause. Any underlying triggers or stimuli should be avoided as much as possible, 158 the pneumoconioses although this may not be practical. The changes seen in pulmonary fibrosis are largely irreversible and there are no definitive treatments. However, there are numerous side-effects to long-term oral steroid treatment, such as osteoporosis and development of cushingoid features. N-acetylcysteine has been shown in some trials to improve outcomes; however, the evidence is not conclusive. There is very little evidence that inhaled therapies such as salbutamol have any benefit. When patients develop severe pulmonary fibrosis which is unresponsive to medical therapy, home oxygen therapy may be necessary, progressing to long-term oxygen therapy. Distribution of lung disease depends on the dust involved: particles measuring less than 2­3 mm in diameter reach the distal alveoli. Two syndromes exist: simple pneumoconiosis and an advanced form, progressive massive fibrosis. The Coal Workers Pneumoconiosis Scheme has been set up specifically for this purpose. Although not all claims are successful, many patients are able to get some compensation for the disease that they have subsequently developed. These patients should be managed in the same way as all other patients in acute respiratory failure (see Ch. Worsening or first presentation of severe pulmonary fibrosis can be treated initially with intravenous corticosteroids, with cyclophosphamide as second-line therapy. Assessment by an intensive care physician should also be made and decisions about ceiling of care discussed with the patient. One must also consider other diagnoses associated with the underlying cause of the pulmonary fibrosis. This is particularly important in those with asbestosis, as they are at risk of mesothelioma. Simple pneumoconiosis Simple pneumoconiosis is the commonest type of pneumoconiosis, reflecting coal dust deposition within the lung. It is asymptomatic and diagnosis is made on the basis of small round opacities in the upper zone on chest X-rays. Progressive massive fibrosis In progressive massive fibrosis, large, round fibrotic nodules measuring more than 10 mm in diameter are seen, usually in the upper lobes. Symptoms include dyspnoea, cough and sputum production (which may be black as cavitating lesions rupture). Lymphocytes and macrophages then infiltrate, leading to the development of noncaseating granulomas, which may resolve or organize, leading to pulmonary fibrosis. Asbestosis Asbestosis is diffuse pulmonary fibrosis caused by the inhalation of asbestos, a mixture of silicates of iron, nickel, magnesium, aluminium and cadmium mined from the ground. Therefore those with occupations such as plumbers, electricians and builders are at high risk of exposure. Several types of asbestos exist: serpentine fibres, which do not cause pulmonary disease, and amphibole fibres, which do. The most important type of amphibole asbestos is crocidolite (blue asbestos), a straight fibre 50 mm long and 1­2 mm wide that cannot be cleared by the immune system. Fibres remain in the lung indefinitely and become coated in iron (haemosiderin) to form the classic drumstick-shaped asbestos bodies. Histology shows asbestos bodies and features of pulmonary fibrosis, affecting the lower lobes more commonly. A considerable time lag, sometimes as long as 20­40 years, exists between exposure and disease development. Bilateral endinspiratory crackles indicate significant diffuse pulmonary fibrosis. Clinical features these consist of cough, shortness of breath, fever and malaise that occur acutely several hours after exposure to antigen. Investigations There are many different ways to investigate extrinsic allergic alveolitis. These include polymorphonuclear leucocyte count, precipitating antibodies (evidence of exposure, not disease), nodular shadowing on chest X-ray, lung function tests showing a restrictive pattern and bronchoalveolar lavage. Treatment Most diseases will regress once the patient is prevented from further exposure to the antigen. Corticosteroids may speed recovery but do not alter the ultimate level of lung function and are thought to be mostly of benefit in severe disease. Also known as fibrosing alveolitis or cryptogenic fibrosing alveolitis, idiopathic pulmonary fibrosis is a rare, progressive chronic pulmonary fibrosis of unknown aetiology. Pathology the alveolar walls are thickened because of fibrosis, predominantly in the subpleural regions of the lower lobes. An increased number of chronic inflammatory cells are in the alveoli and interstitium. Pathogenesis Antigens that can cause allergic lung disease include: · · · · Mouldy hay. Clinical features Clinical features of idiopathic pulmonary fibrosis include progressive breathlessness and a dry cough. There is progression to cyanosis, respiratory failure, pulmonary hypertension and cor pulmonale over time. Clubbing occurs in two-thirds of patients; chest expansion is reduced and bilateral, fine, end-inspiratory crackles are heard on auscultation. Investigations Several investigations are made: · Transbronchial or open-lung biopsy to confirm histological diagnosis. Alveolar proteinosis is associated with a high incidence of concomitant fungal infections and may complicate other interstitial disease. The course of the disease is variable, but the majority of patients enjoy spontaneous remission. A proliferation of macrophages in the alveolar air spaces occurs, along with interstitial thickening by mononuclear inflammatory cells. Desquamative interstitial pneumonitis has a distinctly uniform histological pattern. Typically, patients are aged 40­70 years at presentation; only 2­3% occur in younger patients. Tumours may occur as discrete or mixed histological patterns; the development from the initial malignant change to presentation is variable: · Squamous cell carcinoma: 8 years. Cigarette smoking is the largest contributory factor: · It is related to the amount smoked, duration and tar content: 20% of smokers will develop lung cancer. Environmental and occupational factors include: · Radon released from granite rock. Squamous cell carcinoma Squamous cell carcinoma arises from squamous epithelium in the large bronchi. A strong association between cigarette smoking and squamous cell carcinoma exists. Squamous cell carcinomas are histologically well differentiated and are associated with paraneoplastic syndromes; the cancer commonly produces a substance similar to parathyroid hormone, which leads to hypercalcaemia and bone destruction. The major mass of the tumour may occur outside the bronchial cartilage and encircle the bronchial lumen, producing obstructive phenomena. The tumours are almost always hilar and are prone to massive necrosis and cavitation, with upper-lobe lesions more likely to cavitate. Squamous cell carcinoma is the least likely type to metastasize and, untreated, it has the longest patient survival of any of the bronchogenic carcinomas. Histological types There are four main histological types of bronchogenic carcinoma, subdivided in to non-small-cell and smallcell carcinomas. Adenocarcinomas are associated with diffuse pulmonary fibrosis and honeycomb lung. Bronchogenic tumours associated with occupational factors are mainly adenocarcinomas. In all, 90% of adenocarcinomas occur between 40 and 69 years of age, with the mean age for diagnosis being 53 years. Two-thirds Non-small-cell tumours Squamous cell Incidence (%) Male/female incidence Location Histological stain Relationship to smoking Growth rate Metastasis Treatment Prognosis 52 M>F Hilar Keratin High Slow Late Surgery 2-year survival ¼ 50% Adenocarcinoma 13 F>M Peripheral Mucin Low Medium Intermediate Large-cell 5 M>F Peripheral/ central ­ High Rapid Early Small-cell tumours 30 M>F Hilar ­ High Very rapid Very early Chemotherapy 3 months if untreated; 1 year if treated. Histologically, they are differentiated from other bronchogenic tumours by their glandular configuration and mucin production. As the tumour is commonly in the periphery, obstructive symptoms are rare, so the tumour tends to be clinically silent. Malignant cells are detected in the sputum in 50% of patients, and the commonest radiological presentation is a solitary peripheral pulmonary nodule, close to the pleural surface. Resection is possible in a small proportion of cases; 5-year survival rate is less than 10%. Invasion of the pleura and mediastinal lymph nodes is common, as too is metastasis to the brain and bones. Metastasis to the gastrointestinal tract, pancreas or ovaries must be excluded after having made a diagnosis. Prognosis is very poor, with a mean survival time for untreated patients with small-cell carcinoma of 7 weeks after diagnosis. Interestingly, small-cell carcinoma is the only bronchial carcinoma that responds to chemotherapy. Clinical features Features specific to the histological types have already been introduced above. Diagnosis always needs to be excluded in cigarette smokers who present with recurrent respiratory symptoms: · Persistent cough ­ commonest presentation; may be productive if obstruction leads to infection. Large-cell anaplastic tumour Large-cell anaplastic tumours are diagnosed by a process of elimination. No clear-cut pattern of clinical or radiological presentation distinguishes them from other malignant lung tumours. The point of origin of the carcinoma influences the symptomatic presentation of the disease: central lesions present earlier than peripheral lesions as they cause obstruction.

Recurrent primary liposarcoma of the pericardium: management by repeated resections gastritis symptoms in dogs buy discount misoprostol 100 mcg line. Metastatic and invasive tumours involving the heart in a geriatric population: a necropsy study gastritis diet ãäç effective 100 mcg misoprostol. Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor gastritis symptoms nhs direct order discount misoprostol. Diagnosis of pericardial disease using percutaneous biopsy: case report and literature review gastritis symptoms difficulty swallowing misoprostol 100 mcg order overnight delivery. Intrapericardial treatment of inflammatory and neoplastic pericarditis guided by pericardioscopy and epicardial biopsy-results from a pilot study gastritis diet 7 up cake misoprostol 100 mcg fast delivery. Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Second primary cardiac B-cell lymphoma after radiation therapy and chemotherapy-a case report. Doxorubicin Cardiotoxicity: Clinical Aspects, Recognition, Monitoring, Treatment, and Prevention. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Esophagealpericardial fistula with purulent pericarditis secondary to esophageal carcinoma presenting with tamponade. Cardiac and pericardial fistulae associated with esophageal or gastric neoplasms: a literature review. Gastric cancer presenting as gastropericardial fistula in a patient with familial adenomatous polyposis syndrome. What a cardiologist needs to know about patients with human immunodeficiency virus infection. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival. Cutaneous and pericardial extramedullary hematopoiesis with cardiac tamponade in chronic myeloid leukemia. Amyloidosis of the pericardium in multiple myeloma: an unusual cause of bloody pericardial effusion. Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. Intrapericardial instillation of mitoxantrone in palliative therapy of malignant pericardial effusion. Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer. Pericardioperitoneal shunt: an alternative treatment for malignant pericardial effusion. Complications of conventional therapy include changes in lipid metabolism, cardiovascular and cerebrovascular disease, thromboembolic events. Tamoxifen has become an important component of endocrine therapy for breast cancer. These patients are subject to both the direct effects of neoplastic growth as well as to other predominant causes of mortality, some of which arise from their anticancer therapy. Indeed, a major cause of death in postmenopausal women treated for breast cancer results from cardiovascular disease, a malady that is often enhanced by the very therapeutic regimes used to control or eliminate the neoplastic process. In the United States, as in most industrialized countries, cardiovascular disease remains a major public health concern. This gender gap gradually disappears with advancing age, and after 80 years of life, the incidence of cardiovascular disease in women supersedes that of men. Women with early breast cancer continue to survive longer as increasingly *Portions of this chapter appeared as Ewer, Glück. Many patients may ultimately be more likely to die from causes independent of breast cancer, such as cardiovascular disease than from sequelae attributable or related to breast cancer. It is important to note, however, that despite these benefits, tamoxifen also has been associated with an increased risk of events such as stroke, pulmonary embolism, and deep vein thrombosis (Table 17-1). The Framingham Study also identified obesity as a risk factor in hypertension and cardiovascular disease. Weight increase has been recently observed; the age-adjusted prevalence of overweight or obese women in the United States in 2007­2008 was 64. Often, major clinical studies exclude patients with pre-existing, uncontrolled hypertension or cardiovascular disease for safety reasons. The presence or absence of comorbid conditions in postmenopausal women with breast cancer also has an impact on cardiovascular disease risk. Cardiovascular Disease Risk After Menopause Results from the Framingham Heart Study (N = 2,036) demonstrate that women have lower systolic and diastolic blood pressures, as well as lower pulse pressures and mean arterial pressures than men during the fourth decade of life. This may explain at least in part some of the differences in cardiovascular risk that have been observed in clinical trials. A longer term study of a group of patients in the Scottish adjuvant tamoxifen trial (N = 44) also indicated that tamoxifen consistently and significantly lowered total cholesterol levels and that this effect ended with treatment cessation. Aromatase Inhibitors An open-label, randomized study compared the impact of 24 weeks of treatment with anastrozole, letrozole, or exemestane on lipid parameters in healthy postmenopausal women (N = 90). In addition, lipid profiles were not determined or reported when patients were examined at a 100month follow-up evaluation, leading to inconclusive results. In addition, (90%) of these cholesterol measurements were taken under nonfasting conditions at various times of day. The decrease for patients who were receiving tamoxifen was immediate, whereas the decrease for patients who were receiving letrozole began at approximately 30 months after randomization. In addition, although total cholesterol tended to decrease from baseline in both groups, there was a significant decrease with tamoxifen at 12 months relative to exemestane (P=0. This was a check-listed adverse event that had to be reported at every pateint visit. At a median follow-up of 30 months, an identical incidence of hypercholesterolemia was observed for patients on letrozole and placebo (418 of 2,572 patients [16%] for letrozole versus 411 of 2,577 patients [16%] for placebo; P = 0. At 24 and 36 months, there was no significant difference in the mean percentage change from baseline between groups of fasting patients. Total cholesterol significantly increased in both arms (up until the 24-month follow-up for the exemestane group), with a more obvious elevation in the observation group (mean cholesterol change versus baseline at 24 months, 8. Not unimportant among these was a report of a greater incidence with anastrozole versus tamoxifen (2% vs. Asterisks denote a significant difference between the treatments (see Wasan et al. Thus, regular blood pressure monitoring of patients who are receiving adjuvant exemestane especially in patients with hypertension is clearly indicated. Despite the relatively low overall incidence, and even in the face of the observed oncologic benefit, this disparity is of potential concern and should be further studied. Cardiovascular events classified as ``other" [cardiovascular disorder not otherwise specified, including aneurysm, aortic aneurysm, aortic aneurysm rupture, aortic dilation, aortic stenosis, arteriosclerosis, atherosclerosis, femoral arterial stenosis, hypertensive angiopathy, iliac artery stenosis, and intermittent claudication], were more numerous with letrozole (19 of 2,448 patients [0. The absolute differences, however, were small (<1%), and 160 to 180 patients were needed to observe a single event. Women with pre-existing cardiovascular disease also were more likely to die from causes other than breast cancer (P = 0. Thromboembolic Events Deep vein thrombosis and pulmonary embolism are serious and potentially fatal events, the incidence of which increases with age in both sexes from approximately 1 per 1,000 for persons aged 40 to 75 to 1 per 100 for persons older than 75. Thus, the risk for vascular thrombotic events appears early, that is, in the first 2 years, in tamoxifen-treated patients. Additionally, there were more cases of emboli in tamoxifen-treated patients compared with those who switched to anastrozole (9 [<1%] vs 1[<1%]). The B-42 trial will compare 5 years of treatment with letrozole or placebo in postmenopausal women who have completed 5 years of previous endocrine therapy; it includes the incidence of arterial thromboembolic events as a secondary endpoint. This suggests that tamoxifen does not induce any "carryover" effect on cerebrovascular events. This was identical to that observed in patients who continued on tamoxifen (P = 0. Similar results were reported when events both during treatment and after treatment were considered (2. A 2006 statistic estimated that the annual prevalence of stoke in adults 20 years of age or older was 6. With age, the male/female incidence ratio of stroke decreases; from ages 55­65, the ratio is 1. This decrease was observed as treatment continued, but when treatment ended, the decline ceased (22 events, annual rate 0. In addition, letrozole has been studied in comparison with placebo, and no significant differences were observed. The use of statins, betablockers, and/or angiotensin-converting enzyme inhibitors and sulfonylureas or metformin to manage hyperlipidemia, hypertension, and diabetes, respectively, is appropriate. Body weight and physical activity level are modifiable risk factors for cardiovascular disease and may be overlooked when considering the long-term impact of adjuvant therapy. In one study, 51 postmenopausal women who were overweight or obese had significantly higher serum sex hormone levels, including estradiol, bioavailable estradiol, estrone, and estrone sulfate, whereas an inverse relationship was observed for sex hormone-binding globulin (all P <0. These results were reiterated in multivariate analyses corrected for other prognostic factors. In this study of 1,398 patients which took in to account other prognostic indicators, obesity was independently associated with the existence of angiolymphatic invasion. The general population of women receiving adjuvant endocrine therapy is more likely to have preexisting coronary heart disease risk factors than women who are enrolled in clinical studies. Regular assessment and management of cardiovascular risk is an important component of therapy for women with breast cancer. These benefits may contribute to the apparent cardioprotective effect of tamoxifen and the reduction tamoxifen treatment causes in certain cardiovascular disease endpoints. The potential benefits of tamoxifen therapy on cardiovascular health, however, must be balanced with the risk for recurrence of breast cancer. With improved efficacy in reducing breast cancer recurrences and longer survival after breast cancer diagnosis, cardiovascular disease and other pathological processes will continue to emerge as an important factor influencing the survival of breast cancer patients. Since tamoxifen does not, to any great extent, increase the rate of these events, it may be preferable in some patients, particular those at risk for cardiovascular disease; few studies have addressed this issue. This raises an important concern and calls for additional follow-up and improved study design in the future. Like all patients who are at risk for cardiovascular effects, these patients should be assessed regularly and should be managed to minimize cardiovascular risks during therapy. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomized trial. Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women. Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer Comparison of adverse effects on lipid metabolism of anastrozole with tamoxifen in adjuvant setting for postmenopausal women with early breast cancer [abstract]. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: Effects on body composition and lipids. Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study. Lipid profile and homocysteine levels in postmenopausal women with early breast cancer at low risk treated for 2 years with exemestane: follow-up results of a randomized, placebo-controlled study [abstract]. Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-totreat analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 trial. A placebocontrolled trial examining the effects of letrozole on mammographic breast density and bone and lipid metabolism [abstract]. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Program and abstracts of the 32nd Annual San Antonio Breast Cancer Symposium; December 9­13, 2009; San Antonio, Texas.

Buy misoprostol 100 mcg without prescription. Carnivore Diet Insulin Motility and Acid Reflux Diseases Dr. J Q & A.

References